| Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys JD Jentsch, P Olausson, R De La Garza II, JR Taylor Neuropsychopharmacology 26 (2), 183-190, 2002 | 337 | 2002 |
| Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression CN Haile, JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, A Foulkes, ... International Journal of Neuropsychopharmacology 17 (2), 331-336, 2014 | 258 | 2014 |
| Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches GM Asnis, R De La Garza Journal of clinical gastroenterology 40 (4), 322-335, 2006 | 244 | 2006 |
| Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving TF Newton, JD Roache, R De La Garza, T Fong, CL Wallace, SH Li, ... Neuropsychopharmacology 31 (7), 1537-1544, 2006 | 201 | 2006 |
| Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence S Shoptaw, KG Heinzerling, E Rotheram-Fuller, T Steward, J Wang, ... Drug and alcohol dependence 96 (3), 222-232, 2008 | 196 | 2008 |
| Endotoxin-or pro-inflammatory cytokine-induced sickness behavior as an animal model of depression: focus on anhedonia R De La Garza II Neuroscience & Biobehavioral Reviews 29 (4-5), 761-770, 2005 | 184 | 2005 |
| MDMA use and neurocognition: a meta-analytic review AD Kalechstein, R De La Garza, JJ Mahoney, WE Fantegrossi, TF Newton Psychopharmacology 189, 531-537, 2007 | 161 | 2007 |
| Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. DH Overstreet, RC Commissaris, R De La Garza 2nd, SE File, DJ Knapp, ... Stress (Amsterdam, Netherlands) 6 (2), 101-110, 2003 | 161 | 2003 |
| A distinct neurochemical profile in WKY rats at baseline and in response to acute stress: implications for animal models of anxiety and depression R De La Garza II, JJ Mahoney III Brain research 1021 (2), 209-218, 2004 | 159 | 2004 |
| Perceptions about e-cigarette safety may lead to e-smoking during pregnancy S Baeza-Loya, H Viswanath, A Carter, DL Molfese, KM Velasquez, ... Bulletin of the Menninger Clinic 78 (3), 243-252, 2014 | 134 | 2014 |
| Methamphetamine craving induced in an online virtual reality environment C Culbertson, S Nicolas, I Zaharovits, ED London, II Richard De La Garza, ... Pharmacology Biochemistry and Behavior 96 (4), 454-460, 2010 | 129 | 2010 |
| A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3, 4-methylenedioxymethamphetamine in the mouse WE Fantegrossi, JR Ciullo, KT Wakabayashi, R De La Garza II, ... Neuroscience 151 (2), 533-543, 2008 | 111 | 2008 |
| Theories of addiction: methamphetamine users' explanations for continuing drug use and relapse TF Newton, R De La Garza, AD Kalechstein, D Tziortzis, CA Jacobsen American Journal on Addictions 18 (4), 294-300, 2009 | 109 | 2009 |
| Effects of tobacco smoke and electronic cigarette vapor exposure on the oral and gut microbiota in humans: a pilot study CJ Stewart, TA Auchtung, NJ Ajami, K Velasquez, DP Smith, ... PeerJ 6, e4693, 2018 | 105 | 2018 |
| Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity GM Miller, SM Yatin, R De La Garza II, M Goulet, BK Madras Molecular brain research 87 (1), 124-143, 2001 | 104 | 2001 |
| Cocaine and methamphetamine produce different patterns of subjective and cardiovascular effects TF Newton, R De La Garza II, AD Kalechstein, L Nestor Pharmacology Biochemistry and Behavior 82 (1), 90-97, 2005 | 100 | 2005 |
| Mediation of the discriminative stimulus properties of cocaine by mesocorticolimbic dopamine systems PM Callahan, R De La Garza II, KA Cunningham Pharmacology Biochemistry and Behavior 57 (3), 601-607, 1997 | 100 | 1997 |
| Presence and persistence of psychotic symptoms in cocaine‐versus methamphetamine‐dependent participants JJ Mahoney III, AD Kalechstein, R De La Garza, TF Newton The American journal on addictions 17 (2), 83-98, 2008 | 95 | 2008 |
| The effects of the 5-hydroxytryptamine1A agonist 8-hydroxy-2-(di-n-propylamino) tetralin on spontaneous activity, cocaine-induced hyperactivity and behavioral sensitization: a … R De La Garza, KA Cunningham Journal of Pharmacology and Experimental Therapeutics 292 (2), 610-617, 2000 | 92 | 2000 |
| The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-α induced alterations to monoamine turnover in prefrontal cortex and hippocampus R De La Garza II, GM Asnis Brain research 977 (1), 70-79, 2003 | 89 | 2003 |
James J. MahoneyWest Virginia UniversityVerified email at hsc.wvu.edu
